Inoculation plan from February to March next year
Jung Eun-kyung, head of the Central Defense Countermeasure Headquarters, is giving a briefing on the current status of the outbreak in Korea and plans to introduce a vaccine.[이미지출처=연합뉴스]
–
[아시아경제 김흥순 기자, 조현의 기자] The new coronavirus infectious disease (Corona 19) vaccine introduced in Korea is scheduled to be given first to about 1 million people in high-risk groups living in medical institutions and nursing hospitals and nursing homes from February to March next year.
At a regular briefing on the 28th, Jung Eun-kyung, head of the Central Defense Countermeasure Headquarters, said, “The government plans to make vaccination available immediately from February to March next year when the vaccine is supplied to Korea.” “We are considering high-risk groups living in group facilities such as nursing homes and nursing homes as our top priority.”
Hospitalized/Severe Patients Medical Staff
High-risk facilities such as nursing hospitals, etc.
Priority vaccination of about 1 million people
The number of targets for vaccination that the quarantine authorities estimate is about 1 million. In addition, priority is given to vaccinations over 65 years of age, 19-64 years of age, chronically ill patients with moderate or higher risk, workers and employees of pediatric and adolescent education and childcare facilities, first responders to Corona 19, police, fire fighting officials, and soldiers. “We are preparing a plan to complete vaccinations for those who are recommended for priority vaccination before the influenza epidemic period (November).”
The Korean government has decided to secure a total of 46 million vaccines through multinational associations with overseas pharmaceutical companies. AstraZenekawa and AstraZenekawa signed a vaccine contract for a total of 10 million people on the 27th of last month, and on the 23rd of this month, they also signed a supply contract with Janssen (for 6 million people) and Pfizer (for 10 million people). Modenawa is reviewing a contract to supply 10 million vaccines. It has also signed an agreement with the COVAX facility, an international project for the joint purchase and distribution of vaccines, to supply 10 million people, and is discussing a specific supply schedule.
“The total amount of vaccines for 46 million people purchased by the government, including the planned purchase, accounts for 88.8% of the total population of 51.8 million people in Korea.” “He said. He added, “Considering the academic opinion that 60-70% of the total population needs antibody formation for population immunity, this is a sufficient amount for the formation of domestic population immunity.”
A medical staff member of the Department of Health in the Croydon Autonomous Region in southern London, UK, is preparing to receive and store the first amount of a novel coronavirus infection (Corona 19) vaccine jointly developed by Pfizer-Bioentech at Croydon University Hospital. AP = Yonhap News)
–
Establish a vaccine management system that considers characteristics such as cryogenic distribution and refrigeration storage
After vaccination, check for abnormal reactions, check causality, and compensate the state in case of damage
Corona 19 vaccination is carried out in two ways: operating a separate vaccination center and designating a consignment medical institution in consideration of the characteristics of the vaccine type. For vaccines that require ultra-low temperature distribution at -60 to 90 degrees Celsius, such as Pfizer, about 100 to 250 separate vaccination centers with freezers will be designated and operated. Vaccines that can be stored and distributed in refrigerators such as AstraZeneca and Janssen are administered by designating an institution that meets the designated criteria among consignment medical institutions with existing vaccination experience.
The quarantine authorities are also establishing the’Corona 19 Vaccination Integrated Management System’ to prevent cross-vaccination of the Corona 19 vaccine, which normally requires twice vaccination. In addition to the existing national vaccination system, vaccine supply and management will be conducted here, and vaccination registration and adverse reactions after vaccination will be monitored.
In addition, for adverse reactions that may occur after vaccination, the KCDC-Ministry of Food and Drug Safety joint monitoring system will be established, and the national compensation system will be applied for damages with confirmed causality.
“We are doing our best to introduce vaccines and prepare for safe vaccination. We are continuing to discuss with individual pharmaceutical companies in order to accelerate the domestic supply period and secure additional quantities. I will announce the vaccination plan.”
Reporter Kim Heung-soon sport@asiae.co.kr Reporter Johyun [email protected]
>Please activate JavaScript for write a comment in LiveRe.
–
– .
